Adverse events#333tier 3deferredNew

maude device alert short

cadence: Dailydata: mediumshort only
paper
2014
Source
Lerner, J., Beard, T.R. & Sgouros, T. (2014). "The economic impact of FDA Drug Safety Communications on pharmaceutical equity prices." Journal of Health Economics, 36, 100-114. (Applied to MAUDE device-AE data - analog of FAERS.)
Read the paper →

What it checks

When a medical-device maker accumulates safety reports, we short the stock - pending MAUDE database ingest.

Mechanism

Surge in MAUDE (Manufacturer and User Facility Device Experience) adverse-event reports predicts FDA Safety Communication or Class I/II recall; sponsor stock reprices -8% event-day, -12% over 6mo.

No production champion data for this family yet. Stats appear once the discovery pipeline promotes at least one strategy with this family tag, or once a multi-family blend that includes it earns a champion slot.

Signal rule

7d rolling severity-sum z >= +2.0 (and >= 2.5 strong tier) for device-OEM ticker against trailing 1y baseline -> SHORT T+1; hold 10/20/40 trading days.

Data dependencies

  • daily_prices

    Adjusted-close OHLCV for every US-listed ticker; primary price feed.

  • fda_maude_device_severity_daily

    Worker data table — see services/worker schema.

Expected edge

Paper alpha
-8% event-day, -12% 6mo
Paper window
T+1 to T+40d

Lerner-Beard-Sgouros 2014 analog: -8% event-day, -12% over 6mo on device-recall trigger.

Example tickers where this is likely to fire

Illustrative only — the signal fires based on the live data, not a fixed list.

Related families

Explore maude device alert short on alphactor.ai

See which tickers this family is currently firing on, with live signals and rankings.

For informational and educational purposes only. Not financial advice. Learn more